ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,648.40
      1.01%
      US Tech 100
      18,930.00
      -0.63%
      Dow Jones
      41,563.08
      0.55%
      Brent Oil
      75.535
      -2.14%
      Bitcoin
      59,009.78
      -0.19%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Pharmaxis Ltd (PXS) Quote

      Pharmaxis Ltd

      Pharmaxis Ltd (PXS)

      Provexis Plc
      Pyxis Tankers Inc
      Paragon Care Limited
      Invesco FTSE RAFI US Fundamental Index ETF II
      0.027
      0.00
      (0.00%)
      Closed September 03 2:00AM
      Delayed by 20 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.027
      Bid
      0.026
      Ask
      0.027
      Volume
      0.00
      0.00 Day's Range 0.00
      0.0265 52 Week Range 0.041
      Market Cap
      19.429M
      Previous Close
      0.027
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      0.00
      Shares Outstanding
      719,584,000
      Dividend Yield
      -
      PE Ratio
      -1.90
      Earnings Per Share (EPS)
      -0.02
      Revenue
      12.96M
      Net Profit
      -11.36M

      About Pharmaxis Ltd

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.pharmaxis.com.au
      Headquarters
      Sydney, New South Wales, Aus
      Founded
      1970
      Pharmaxis Ltd is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker PXS. The last closing price for Pharmaxis was AUD0.03. Over the last year, Pharmaxis shares have traded in a share price range of AUD 0.0265 to AUD 0.041.

      Pharmaxis currently has 719,584,000 shares outstanding. The market capitalization of Pharmaxis is AUD19.43 million. Pharmaxis has a price to earnings ratio (PE ratio) of -1.90.

      Ask ADVFN Intelligence (AI)

      PXS Latest News

      More News

      FDA Bronchitol Approval to Generate Cash Flows for Pharmaxis

      It is the gold standard of success in biotech, but not many Australian companies can boast it – approval from the United States Food & Drug Administration (FDA) of a medicine you have...

      November 02 2020
      Business Wire

      Here’s why Pharmaxis Ltd. shares are soaring today

      http://www.fool.com.au/2015/03/12/heres-why-pharmaxis-ltd-shares-are-soaring-today/

      March 11 2015
      The Motley Fool

      NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic Fibrosis Patients

      NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic Fibrosis Patients NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic...

      October 26 2012
      PR Newswire (US)

      Pharmaxis Receives Approval to Market Bronchitol in the EU

      Pharmaxis Receives Approval to Market Bronchitol in the EU PR Newswire ELTVILLE, Germany, April 27, 2012 ELTVILLE, Germany, April 27, 2012 /PRNewswire/ -- Pharmaceutical company Pharmaxis (ASX:...

      April 27 2012
      PR Newswire (US)

      Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code

      Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code J7665 mannitol administered through inhaler PR Newswire EXTON, Pa., Jan. 3, 2012 EXTON, Pa., Jan. 3...

      January 03 2012
      PR Newswire (US)

      Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit

      Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit ARIDOL is the Only Dry Powder Bronchial Challenge Test Approved for Use in the U.S. PR...

      November 07 2011
      PR Newswire (US)

      Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe

      Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe PR Newswire SYDNEY, October 26, 2011 SYDNEY, October 26, 2011 /PRNewswire/ -- Pharmaceutical company Pharmaxis...

      October 26 2011
      PR Newswire (US)

      Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe

      Pharmaceutical company Pharmaxis (ASX: PXS) today announced the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of...

      October 24 2011
      Business Wire

      Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe

      Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe PR Newswire SYDNEY, Oct. 24, 2011 SYDNEY, Oct. 24, 2011 /PRNewswire/ -- Pharmaceutical company Pharmaxis (ASX: PXS...

      October 24 2011
      PR Newswire (US)

      CHMP Recommends Marketing Authorization For Trajenta, Votubia

      The Committee for Medicinal Products for Human Use, or CHMP, said Friday that it has adopted positive opinions recommending the granting of marketing authorizations for Trajenta-linagliptin, from...

      June 24 2011
      Dow Jones News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DE
      40000000DE
      120000000DE
      260000000DE
      52-0.013-32.50.040.0410.02652011330.03395038DE
      156-0.108-800.1350.150.02654288050.07474876DE
      260-0.163-85.78947368420.190.2850.02657130050.09173904DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GEDGolden Deeps Limited
      AUD 0.074
      (164.29%)
      		97.01M
      LSRLodestar Minerals Limited
      AUD 0.0015
      (50.00%)
      		2.5M
      CTNCatalina Resources Ltd
      AUD 0.003
      (50.00%)
      		782.71k
      1TTThrive Tribe Technologies Ltd
      AUD 0.0015
      (50.00%)
      		654.5k
      CYQCYCLIQ Group Limited.
      AUD 0.004
      (33.33%)
      		2.9M
      CXUOCauldron Energy Ltd
      AUD 0.009
      (-55.00%)
      		250k
      D2OOADuxton Water Limited
      AUD 0.01
      (-41.18%)
      		5.58k
      ARVOCArtemis Resources Limited
      AUD 0.002
      (-33.33%)
      		2M
      MTBMount Burgess Mining Nl
      AUD 0.001
      (-33.33%)
      		371
      ILAOIsland Pharmaceuticals Limited
      AUD 0.015
      (-25.00%)
      		200k
      GEDGolden Deeps Limited
      AUD 0.074
      (164.29%)
      		97.01M
      STXStrike Energy Limited
      AUD 0.20
      (3.90%)
      		89.07M
      SLCSuperloop Limited
      AUD 1.69
      (-2.87%)
      		60.82M
      IMUImugene Limited
      AUD 0.062
      (-8.82%)
      		58.66M
      LDXLumos Diagnostics Holdings Ltd
      AUD 0.046
      (6.98%)
      		46.06M

      Discussion

      View Full Feed
      trader_ron trader_ron 4 minutes ago
      $SMCE - Announces Launch of Chaintrade, its AI-Powered Platform Revolutionizing Data Intelligence in Capital Markets
      https://www.otcmarkets.com/stock/SMCE/news/SMCE-OTC-SMCE-Announces-Launch-of-Chaintrade-its-AI-Powered-Platform-Revolutionizing-Data-Intelligence-in-Capital-Market?id=450539
      SMCE
      PEACHMAN PEACHMAN 4 minutes ago
      IFUS will indeed move up in Sept and the remainder of 2024 and hit new highs in 2025 for several reasons.

      HCR 42 the legislation that was passed in the House and the Senate will have initial research validation and commerlization of bagasses finished by Feb 2 and published that will
      IFUS
      trader_ron trader_ron 4 minutes ago
      $SMCE - Announces Launch of Chaintrade, its AI-Powered Platform Revolutionizing Data Intelligence in Capital Markets
      https://www.otcmarkets.com/stock/SMCE/news/SMCE-OTC-SMCE-Announces-Launch-of-Chaintrade-its-AI-Powered-Platform-Revolutionizing-Data-Intelligence-in-Capital-Market?id=450539
      SMCE
      ysung ysung 5 minutes ago
      Excellent !!!!!

      Supposedly CEO paid penny a share for
      1.2 billion shares
      HIRU
      Fannie Heyyyyy Fannie Heyyyyy 6 minutes ago
      We are in our 7th week now since the defendants sent their rebuttal to Lamberth. 7 weeks!!! Think he submits his opinion this week?
      biosectinvestor biosectinvestor 8 minutes ago
      Charles Schwab lets me buy immediately. Only the first buy ever of any penny stock of any sort has the 3 day delay. That’s to see if you still want to do it because it’s a penny stock, after that it’s like any other stock. I know of few brokerages that don’t do that in the very first buy. As for sel
      NWBO
      Laster Laster 9 minutes ago
      Bought some AH Friday. What a huge mistake.
      Looks like today it will retrace back to $0.50 or lower.
      Oh well.
      APTO
      reena969 reena969 9 minutes ago
      SIFY, question is are we going to have the same 7am dump as Friday's BNRG?? There has been some BIG buy's . the main reason I've been in and out , however holding a .75 , 4:39am entry
      BNRG SIFY
      Laster Laster 10 minutes ago
      What a frikkin drop last week.
      I don’t even need to look.
      Chinese scam?
      Enjoy the bounce.
      reena969 reena969 13 minutes ago
      SIFY RSI making higher high's $$$$$$ riding upper Bollinger $$$ .8646 support
      SIFY
      eur06 eur06 14 minutes ago
      Thanks dino I had not even looked at this one.
      HIRU
      HIRU
      rolvram rolvram 16 minutes ago
      President Capital Adjusts Price Target on NVIDIA to $152 From $140, Maintains Buy Rating
      05:48:12 AM ET, 09/03/2024 - MT Newswires
      05:48 AM EDT, 09/03/2024 (MT Newswires) -- NVIDIA (NVDA) has an average buy rating and a price target range of $90 to $200, according to analysts polled by
      NVDA
      gdog gdog 17 minutes ago
      you blaming covid on Trump ? enjoying? I said everything was cheaper thats just a fact.
      JJZander JJZander 18 minutes ago
      BNCM news out - BNCM Announces 11 New Products from DELEX PHARMA to Propel Growth
      Press Release | 09/03/2024
      3rd September 2024, Quezon City, Philippines Delex Pharma International Inc. has launched an impressive array of 11 new pharmaceutical products in the first half of 2024, settin
      BNCM
      reena969 reena969 18 minutes ago
      SIFY middle bollinger band support .844 was really hoping for the lower band to be the last support. .825

      OH well off to the races
      SIFY
      ALDRADJKD123 ALDRADJKD123 19 minutes ago
      Kamala Harris’ alleged policy,

      https://youtu.be/LImZlrLaUWc?si=sCpvCTtSMIzHIxmr
      Golf4Food Golf4Food 19 minutes ago
      Heres your BLUE - https://stockcharts.com/c-sc/sc?s=BLUE&p=D&yr=1&mn=0&dy=0&i=t8629359258c&r=1725359536007
      TJG TJG 21 minutes ago
      The Affluence people are back listed as the officers false alarm
      AFFU
      71chris71 71chris71 21 minutes ago
      Penny, you have shown here that you have skills, why don't you meet Nixon? Surely you are closer than me
      JJZander JJZander 21 minutes ago
      BNCM Announces 11 New Products from DELEX PHARMA to Propel Growth
      Press Release | 09/03/2024
      3rd September 2024, Quezon City, Philippines Delex Pharma International Inc. has launched an impressive array of 11 new pharmaceutical products in the first half of 2024, setting the stage for
      BNCM
      Golf4Food Golf4Food 23 minutes ago
      https://stockcharts.com/c-sc/sc?s=INTC&p=W&yr=5&mn=0&dy=0&i=t0153345695c&r=1725359338607
      INTC
      op1 op1 23 minutes ago
      Great info
      Should send it to kidron
      WDDD
      NASDAQ2020 NASDAQ2020 23 minutes ago
      You forgot to change IDs
      ELTP

      Your Recent History

      ASX
      PXS
      Pharmaxis
      Delayed Upgrade Clock